Patents by Inventor Michael Rogowski

Michael Rogowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250134945
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Application
    Filed: January 6, 2025
    Publication date: May 1, 2025
    Applicant: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski
  • Patent number: 12186358
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise: administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Grant
    Filed: February 17, 2022
    Date of Patent: January 7, 2025
    Assignee: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski
  • Publication number: 20220257692
    Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise: administering to the subject one or more effective doses of an immune-enhancing natural-based composition; thereby stimulating increased expression one or more of IFN-?, IL-1B, IL-6, IL-10, IL-12p40, IL-12p70, and TNF-?; inhibiting replication of the virus inside a cell of the subject, and preventing entry of virus into the cell. The method of increasing immunity can further comprise increasing immunity to an upper respiratory tract viral infection. The upper respiratory tract viral infection can be COVID-19. According to some aspects of the method of increasing immunity, the effective dose of the immune-enhancing natural-based composition comprises: 30-70 mgs of cyanidin-3-glucosides; 40-80 mgs of andrographolides; 75-125 mgs of ascorbic acid; 400-600 mgs of beta glucans; 300-500 mgs of polysaccharides; and 75-125 mgs of a blend of antioxidants.
    Type: Application
    Filed: February 17, 2022
    Publication date: August 18, 2022
    Applicant: Plexus Worldwide, LLC
    Inventors: Michael Hartman, Lauren Knutsen, Michael Rogowski